Research on fragile X syndrome, the most common inherited cause of mental retardation, has focused mostly on how the genetic defect alters the functioning of neurons in the brain. A new study focusing ...

Fragile X syndrome, the most common form of inherited intellectual disability, may be unfolding in brain cells even before birth, despite typically going undiagnosed until age 3 or later. A new study ...

Scientists have created a new therapeutic approach for testing fragile X syndrome, which is the most common genetic cause of autism spectrum disorder (ASD). This method aims to alter a type of neural ...

That search for answers would ultimately lead to genetic testing, where Robin and her family learned that Sam has a rare genetic condition known as Fragile X syndrome (FXS), caused by a change in the ...

Researchers have developed an innovative new nanopore sequencing assay to identify carriers of fragile X syndrome (FXS), the leading cause of monogenic autism spectrum disorder and inherited ...

Nearly a year and a half ago, I penned my final “From the Editor” column for Lowcountry Parent, sharing publicly for the first time about my son Archer’s diagnosis of Fragile X syndrome at 3 years old ...

OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announced the U ...

The MarketWatch News Department was not involved in the creation of this content. -- Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi ...

An antisense therapy developed by Joel D. Richter, PhD, Sneha Shah, PhD, and Jonathan K. Watts, PhD, at UMass Chan Medical School and Elizabeth Berry-Kravis, MD, PhD, at RUSH University Medical Center ...

U.S. FDA Previously Granted Orphan Disease Designation and Fast Track Designation to SPG601 LOS ANGELES, Feb. 11, 2025 /PRNewswire/ -- Spinogenix, Inc., a clinical-stage biopharmaceutical company ...

WASHINGTON (Reuters) - Genetic engineering can correct the worst symptoms in mice with Fragile X syndrome, the most common inherited cause of mental retardation and autism, U.S. researchers reported ...

Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company KER-0193, a novel, orally bioavailable small molecule, was granted Orphan ...